000 00961 a2200277 4500
005 20250510211056.0
264 0 _c19781202
008 197812s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(78)92671-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCorenblum, B
245 0 0 _aBromocriptine in pituitary tumours.
_h[electronic resource]
260 _bLancet (London, England)
_cOct 1978
300 _a786 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdenoma
_xdrug therapy
650 0 4 _aAntineoplastic Agents
650 0 4 _aBromocriptine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aParaneoplastic Endocrine Syndromes
_xdrug therapy
650 0 4 _aPituitary Neoplasms
_xdrug therapy
650 0 4 _aProlactin
_xmetabolism
773 0 _tLancet (London, England)
_gvol. 2
_gno. 8093
_gp. 786
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(78)92671-5
_zAvailable from publisher's website
999 _c78763
_d78763